AU2002317063A - Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same - Google Patents

Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same

Info

Publication number
AU2002317063A
AU2002317063A AU2002317063A AU2002317063A AU2002317063A AU 2002317063 A AU2002317063 A AU 2002317063A AU 2002317063 A AU2002317063 A AU 2002317063A AU 2002317063 A AU2002317063 A AU 2002317063A AU 2002317063 A AU2002317063 A AU 2002317063A
Authority
AU
Australia
Prior art keywords
granulations
itraconazole
oral administration
pharmaceutical formulations
preparing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002317063A
Other versions
AU2002317063A1 (en
Inventor
Horst Zerbe
Richard Swettenham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SMARTRIX TECHNOLOGIES Inc
Original Assignee
SMARTRIX TECHNOLOGIES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SMARTRIX TECHNOLOGIES Inc filed Critical SMARTRIX TECHNOLOGIES Inc
Publication of AU2002317063A1 publication Critical patent/AU2002317063A1/en
Publication of AU2002317063A publication Critical patent/AU2002317063A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002317063A 2001-06-12 2002-06-12 Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same Withdrawn AU2002317063A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29726001P 2001-06-12 2001-06-12
US60/297,260 2001-06-12

Publications (2)

Publication Number Publication Date
AU2002317063A1 AU2002317063A1 (en) 2002-12-23
AU2002317063A true AU2002317063A (en) 2002-12-23

Family

ID=23145542

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002317063A Withdrawn AU2002317063A (en) 2001-06-12 2002-06-12 Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same

Country Status (2)

Country Link
AU (1) AU2002317063A (en)
WO (1) WO2002100407A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100557680B1 (en) * 2002-11-23 2006-03-07 한국유나이티드제약 주식회사 Pellet preparations and methods for improved solubility of itraconazole
WO2005107702A2 (en) * 2004-05-11 2005-11-17 Glenmark Pharmaceuticals Limited Sustained release, mucoadhesive vaginal pharmaceutical compositions
GB0428152D0 (en) * 2004-12-22 2005-01-26 Novartis Ag Organic compounds
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose
CN109172532A (en) * 2018-10-24 2019-01-11 北京哈三联科技有限责任公司 A kind of itraconazole dispersible tablets and its preparation method and application
WO2022264004A1 (en) * 2021-06-13 2022-12-22 Glenmark Pharmaceutical Limited Pharmaceutical composition comprising itraconazole

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE03902B1 (en) * 1996-05-20 2002-12-16 Janssen Pharmaceutica N.V. Particles, method and preparation thereof, pharmaceutical dosage form and method of preparation, solid dispersion and pharmaceutical packaging
ATE241969T1 (en) * 1997-03-26 2003-06-15 Janssen Pharmaceutica Nv TABLETS HAVING A CORE COATED WITH AN ANTIFUNGAL AND A POLYMER
KR19990001564A (en) * 1997-06-16 1999-01-15 유충식 Azole antifungal agents with improved solubility and preparations containing them
WO1999033467A1 (en) * 1997-12-31 1999-07-08 Choongwae Pharma Corporation Method and composition of an oral preparation of itraconazole

Also Published As

Publication number Publication date
WO2002100407A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
IL162293A0 (en) Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
HUP0303800A3 (en) Pharmaceuticals and dosage forms of epothilones for oral administration
HUP0101246A3 (en) Novel galenic formulations of meloxicam for oral administration and process for their preparation
PL356358A1 (en) Solid dosage form of someticone for oral administration
EP1365747A4 (en) Oral peptide pharmaceutical dosage form and method of production
IL166489A (en) Two-layerd oral dosage form for once-a-day administration of paliperidone and uses thereof
HK1072898A1 (en) Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles
HUP0400281A3 (en) Pharmaceutical compositions of adsorbates of amorphous drug and process for their preparation
PL396568A1 (en) Crystalline O-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline O-desmethyl-venlafaxine succinate
HUP0203451A3 (en) Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
AU2002352974A8 (en) Formulations for oral administration of cromolyn sodium
HUP0004050A3 (en) Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same
GB0100758D0 (en) Immunogenic complex method of preparation thereof and pharmaceutical compositions containing the same, useful for disease control
HK1047231A1 (en) Oral pharmaceutical forms of administration with adelayed action with tramadol
NO20042565L (en) Oral pharmaceutical products containing 17 beta-ostradiol-3-lower alkanoate, methods of administration thereof and methods of preparation thereof
AU2001226029A1 (en) Pharmaceutical formulation and method for pulmonary and oral delivery
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
IL162666A0 (en) A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
AU2002317063A (en) Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
AU2002317063A1 (en) Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
HUP0500958A2 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them
IL162510A0 (en) Pharmaceutical suspension for oral administration

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase